logo-loader

XPhyto Therapeutics looking to hit milestones in 2021 as they move to development and manufacturing

Published: 18:56 29 Jan 2021 EST

XPhyto Therapeutics (CSE: XPHY- OTCQB: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive with news the company has set out a very aggressive work plan for 2021. Rogers talks about some of the milestones they are planning this year including Clinical Studies, Development, and Manufacturing.

Ramp Metals Launches Drilling Program in Pursuit of High-Grade Nickel in...

Ramp Metals CEO Jordan Black joined Steve Darling from Proactive to introduce the company to the public domain and share exciting developments in the mining industry. With a background as a geotechnical engineer and experience in venture capital, including a notable role in taking GoldSpot...

1 hour, 28 minutes ago